Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Financial Debts: $33,537M in FY2025, up 13.3% from a year earlier.
Latest, FY2025
33,537
Period ended Dec 31, 2025
Change on a year earlier
+13.3%
29,598 in FY2024
History
5 years
Since FY2021
Sources
5
Documents cited below
Where the FY2025 figure comes from
“|| Total financial debts | – 46 349 | – 33 537 | – 30 118”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Financial Debts ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 33,537 | +13.3% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 29,598 | +20.3% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 24,611 | -6.0% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 26,175 | -10.4% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 29,197 | – | Novartis Form 6-K (0001370368-22-000077) ↗ |
Cite this data
StockData. (2026). Novartis Total Financial Debts ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/nd-total-fin-debts
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.